Pimavanserin substantially reduces symptoms of psychosis and relapse risk for people living with dementia.
Pimavanserin substantially reduces symptoms of psychosis and relapse risk for people living with dementia.Pimavanserin substantially reduces symptoms of psychosis and relapse risk for people living with dementia.